Merck's $9.2B Cidara Takeover: Big Pharma's Fight for Flu Innovation

Merck wins bidding war for Cidara Therapeutics at $9.2B, more than double its market value, securing groundbreaking long-acting flu antibody treatment as Big Pharma races for cutting-edge medicines.